The short version
Only one company currently supplies this market — there is no backup if it stumbles.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Ed Bron Gp
GUAIFENESIN and PHENYLEPHRINE · GUAIFENESIN 100 mg/5mL; PHENYLEPHRINE HYDROCHLORIDE 5 mg/5mL · Liquid · Oral · Edwards Pharmaceuticals, Inc.
NDC 00485-0208-16 · 473 mL in 1 BOTTLE, PLASTIC · UNAPPROVED DRUG OTHER · View full market →
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Medicaid spend (2025)
$4,850
612 prescriptions paid by Medicaid nationally · all Medicaid spend →
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Regulatory
- Application
- —
- TE code
- —
- Approval date
- —
- Patents / exclusivity
- —
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of GUAIFENESIN and PHENYLEPHRINE (Liquid)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Edwards Pharmaceuticals, Inc. | GUAIFENESIN 100 mg/5mL; PHENYLEPHRINE HYDROCHLORIDE 5 mg/5mL | Jul 15, 2026 | Sep 2, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Ed Bron Gp — NDC 00485-0208-16," retrieved September 3, 2026, https://drugdashboards.com/drug/00485020816.
Free to cite with attribution — see how the data is put together.